Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study – ERRATUM

Sato, Ayako; Fujimori, Maiko; Shirai, Yuki; Umezawa, Shino; Mori, Masanori; Jinno, Sayaka; Umehashi, Mihoto; Okamura, Mutsumi; Okusaka, Takuji; Majima, Yoshiyuki; Miyaké, Satoshi; Uchitomi, Yosuke

doi:10.1017/s1478951522000153

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…QPLs have been found to increase the total number of questions asked (Butow et al, 1994;Brown et al, 1999Brown et al, , 2001Clayton et al, 2003Clayton et al, , 2007. Most patients describe QPLs as helpful and useful to help them ask more questions (McJannett et al, 2003;Langbecker et al, 2012), value them to gather new trial information (Brown et al, 2011a), and generally endorse their early implementation into the consent process of active cancer treatment (Sato et al, 2021). In relation to cancer research, QPLs have been shown to increase treatment-related knowledge and reduce patient's decisional conflict (Jayasekera et al, 2020).…”

Section: Current Research On Question Prompt Listsmentioning

confidence: 99%

Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials

Schönau

Goering²,

Versalovic³

et al. 2022

Front. Hum. Neurosci.

View full text Add to dashboard Cite

Implantable neurotechnology devices such as Brain Computer Interfaces (BCIs) and Deep Brain Stimulators (DBS) are an increasing part of treating or exploring potential treatments for neurological and psychiatric disorders. While only a few devices are approved, many promising prospects for future devices are under investigation. The decision to participate in a clinical trial can be challenging, given a variety of risks to be taken into consideration. During the consent process, prospective participants might lack the language to consider those risks, feel unprepared, or simply not know what questions to ask. One tool to help empower participants to play a more active role during the consent process is a Question Prompt List (QPL). QPLs are communication tools that can prompt participants and patients to articulate potential concerns. They offer a structured list of disease, treatment, or research intervention-specific questions that research participants can use as support for question asking. While QPLs have been studied as tools for improving the consent process during cancer treatment, in this paper, we suggest they would be helpful in neurotechnology research, and offer an example of a QPL as a template for an informed consent tool in neurotechnology device trials.

show abstract

Section: Current Research On Question Prompt Listsmentioning

confidence: 99%

Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials

Schönau

Goering²,

Versalovic³

et al. 2022

Front. Hum. Neurosci.

View full text Add to dashboard Cite

show abstract

Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study – ERRATUM

Abstract: Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study -ERRATUM.

Cited by 1 publication

References 1 publication

Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials

Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials

Contact Info

Product

Resources

About